Author name: Ananta Kar

Ananta is wrapping up her postgraduate studies in Comparative Literature whilst juggling a solid two-year writing career. She cut her teeth as a sports journalist before discovering her true passion: India's exploding gaming scene. These days, she's obsessed with how gaming culture is reshaping the country, and her academic research chops bring unexpected depth to every piece. Whether dissecting esports trends or exploring biologics in India, renewable energy, electric Vehicles & Smart Transportation topics, Ananta writes with the curiosity of a researcher and the energy of someone who genuinely loves what they do.

Avatar photo

Price Drop: India Slashes Ev Charger Costs by 28% to Supercharge Infrastructure Rollout

On February 5, 2026, India’s Ministry of Heavy Industries delivered a jolt to the electric vehicle charging sector with sweeping benchmark price reductions ranging from 13% to 28% across different charger capacities. A 60-kilowatt charger’s benchmark price plummeted 28% to £3,040, down from £6,520 for the previous 50-kilowatt equivalent, whilst 100-kilowatt units dropped from approximately […]

Price Drop: India Slashes Ev Charger Costs by 28% to Supercharge Infrastructure Rollout Read More »

India’s ₹10,000 Crore Gamble: Turning the World’s Cheapest Pill Maker Into a Biologics Powerhouse

Finance Minister Nirmala Sitharaman‘s February 1, 2026, Union Budget contained a declaration of pharmaceutical ambition that industry leaders are calling transformative: Biopharma Shakti, a ₹10,000 crore five-year initiative designed to vault India from its established position as the world’s generics pharmacy—commanding 20% of global volume in small-molecule drugs—toward the technically demanding and far more lucrative

India’s ₹10,000 Crore Gamble: Turning the World’s Cheapest Pill Maker Into a Biologics Powerhouse Read More »

India Just Bet ₹10,000 Crore That It Can Beat the World at Making Biologic Drugs

Finance Minister Nirmala Sitharaman‘s February 1, 2026, Union Budget delivered what pharmaceutical industry leaders are already calling a “defining moment”—Biopharma Shakti, a ₹10,000 crore five-year initiative designed to catapult India from its comfortable position as the world’s generics pharmacy commanding 20% global volume toward the far more lucrative and technically demanding frontier of biologics and

India Just Bet ₹10,000 Crore That It Can Beat the World at Making Biologic Drugs Read More »

Uttar Pradesh Just Declared War on Gujarat’s Pharma Dominance—With ₹40,000 Crore in Ammunition

Uttar Pradesh’s inaugural Pharma Conclave 1.0 at Lucknow’s Taj Mahal Hotel on February 3, 2026, assembled India’s pharmaceutical royalty—Sun Pharma‘s Dilip Shanghvi, Dr Reddy’s Satish Reddy, Zydus‘ Pankaj Patel, Mankind‘s Ramesh Juneja—for what amounts to a declaration of intent: India’s most populous state wants to become its pharmaceutical powerhouse, wresting leadership from established hubs through

Uttar Pradesh Just Declared War on Gujarat’s Pharma Dominance—With ₹40,000 Crore in Ammunition Read More »

India’s Pharma Giants Just Got a ₹20,000 Crore Gift—and Wall Street Noticed Within Minutes

President Donald Trump’s February 2, 2026, Truth Social announcement slashing US reciprocal tariffs on Indian goods from 50% to 18%—whilst simultaneously waiving the 25% penalty on India’s Russian oil purchases—delivered an immediate and dramatic reward to India’s pharmaceutical sector before most Indian markets had even opened for trading. Nifty Pharma surged 2.96% by 9:28 AM

India’s Pharma Giants Just Got a ₹20,000 Crore Gift—and Wall Street Noticed Within Minutes Read More »

Trump Just Cut India’s Tariffs by 7 Points—and the Markets Didn’t Wait to Celebrate

President Donald Trump‘s February 2, 2026, Truth Social announcement—reducing US reciprocal tariffs on Indian goods from 25% to 18% whilst simultaneously waiving the 25% penalty on India’s Russian oil purchases following New Delhi‘s purchase halt—sent immediate shockwaves through global financial markets that India’s economy had been waiting to receive. GIFT Nifty surged 800 points within

Trump Just Cut India’s Tariffs by 7 Points—and the Markets Didn’t Wait to Celebrate Read More »

Yamaha Just Crashed India’s Electric Scooter Party—and It Brought Japanese Precision to the Fight

India’s electric two-wheeler market just received its most significant premium entrant: Yamaha’s EC-06, arriving on February 3, 2026, at ₹1,67,600 ex-showroom Delhi, into a segment where Ola and Ather have been slugging it out for market dominance whilst consumers remained largely confined to existing options. The world’s largest scooter market, accounting for 95% of India’s

Yamaha Just Crashed India’s Electric Scooter Party—and It Brought Japanese Precision to the Fight Read More »

India’s Budget Spent ₹10,000 Crore on Pharma Innovation but Forgot Primary Healthcare

Finance Minister Nirmala Sitharaman’s Union Budget 2026-27, unveiled on February 1, presents a curious paradox in India’s healthcare priorities: a bold ₹10,000 crore Biopharma Shakti scheme championing domestic biologics and biosimilars innovation alongside customs duty waivers on 17 cancer drugs and seven rare disease therapies that could slash monthly treatment costs from ₹70,000-₹95,000—yet an overall

India’s Budget Spent ₹10,000 Crore on Pharma Innovation but Forgot Primary Healthcare Read More »

India’s Budget 2026 Just Made Electric Vehicles Cheaper Without Saying a Word About Cars

Finance Minister Nirmala Sitharaman’s Union Budget 2026-27, tabled on February 1, contains no headline-grabbing direct subsidies for automobile purchasers—yet beneath the surface lies a structural transformation that could shave ₹1-2 lakh off electric vehicle prices whilst insulating India’s automotive supply chains from Chinese dominance. Against the backdrop of GST 2.0‘s September 2025 recalibration that established

India’s Budget 2026 Just Made Electric Vehicles Cheaper Without Saying a Word About Cars Read More »

India Just Told China “No” at the WTO—and the Ev Trade War Got Real

On January 27, 2026, India delivered an unambiguous message to Beijing at the World Trade Organisation’s Dispute Settlement Body: “not today.” New Delhi blocked China’s inaugural panel request challenging India’s Production-Linked Incentive schemes for automobiles, Advanced Chemistry Cell batteries, and electric passenger cars—a strategic veto that buys time whilst fortifying the nation’s self-reliance ambitions against

India Just Told China “No” at the WTO—and the Ev Trade War Got Real Read More »

Scroll to Top